Skip to main content

Table 4 Predictive factors for continued administration of tolvaptan for 1 year

From: Impact of continued administration of tolvaptan on cirrhotic patients with ascites

  Odds ratio 95% confidence interval p-value
Change in BW after 1 week (kg) 1.320 1.083–1.608 0.006
Albumin (g/dL) 4.280 1.136–16.127 0.032
eGFR (mL/min/1.73 m2) 0.978 0.958–0.999 0.045
  1. Changes in body weight (BW), complications including gastroesophageal varices, hepatocellular carcinoma, and hepatic encephalopathy, and lab values including estimated glomerular filtration rate (eGFR) and serum levels of albumin, total bilirubin, aspartate aminotransferase, and sodium were assessed using multivariate logistic regression analyses